Charles River Laboratories (CRL)

Cash ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Cash and cash equivalents	US$ in thousands	194,606	210,171	179,213	327,039	276,771	157,174	200,445	201,587	233,912	193,701	200,321	241,869	241,214	212,539	222,969	465,411	228,424	242,879	402,020	372,433
Short-term investments	US$ in thousands	—	—	—	—	—	—	—	—	—	950	1,012	1,065	1,063	1,030	1,037	1,025	1,024	963	929	934
Total current liabilities	US$ in thousands	994,101	1,012,220	947,519	954,810	1,055,080	993,816	1,007,620	981,392	1,091,580	1,014,190	1,048,140	993,839	1,033,180	983,751	929,610	803,376	839,751	787,014	727,936	690,896
Cash ratio		0.20	0.21	0.19	0.34	0.26	0.16	0.20	0.21	0.21	0.19	0.19	0.24	0.23	0.22	0.24	0.58	0.27	0.31	0.55	0.54

December 31, 2024 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($194,606K + $—K) ÷ $994,101K
= 0.20

The cash ratio for Charles River Laboratories has shown some fluctuations over the periods provided. The ratio, which measures a company's ability to cover its current liabilities with its cash and cash equivalents, ranged from a low of 0.16 to a high of 0.58.

During the period, the cash ratio hovered around a relatively stable range but exhibited some variability. Notably, there was a significant increase from 0.31 on September 30, 2020, to 0.58 on March 31, 2021, indicating an improvement in the company's liquidity position during that time. However, there were subsequent declines in the ratio, with the lowest point observed at 0.16 on September 30, 2023.

Overall, the cash ratio for Charles River Laboratories suggests that the company has generally maintained a reasonable level of liquidity, although there were some periods of fluctuations. It is essential for stakeholders to monitor this ratio over time to assess the company's ability to meet its short-term obligations with its available cash resources.